Wu Yi Fang - Net Worth and Insider Trading

Wu Yi Fang Net Worth

The estimated net worth of Wu Yi Fang is at least $17 Million dollars as of 2024-06-16. Wu Yi Fang is the Director of Shanghai Fosun Pharmaceutical (Group) Co Ltd and owns about 749,900 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) stock worth over $17 Million. Details can be seen in Wu Yi Fang's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Wu Yi Fang has not made any transactions after 2022-09-13 and currently still holds the listed stock(s).

Transaction Summary of Wu Yi Fang

To

Wu Yi Fang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wu Yi Fang owns 1 companies in total, including Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) .

Click here to see the complete history of Wu Yi Fang’s form 4 insider trades.

Insider Ownership Summary of Wu Yi Fang

Ticker Comapny Transaction Date Type of Owner
SHSE:600196 Shanghai Fosun Pharmaceutical (Group) Co Ltd 2022-09-13 Director

Wu Yi Fang Latest Holdings Summary

Wu Yi Fang currently owns a total of 1 stock. Wu Yi Fang owns 749,900 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) as of September 13, 2022, with a value of $17 Million.

Latest Holdings of Wu Yi Fang

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SHSE:600196 Shanghai Fosun Pharmaceutical (Group) Co Ltd 2022-09-13 749,900 23.18 17,382,682

Holding Weightings of Wu Yi Fang


Wu Yi Fang Form 4 Trading Tracker

According to the SEC Form 4 filings, Wu Yi Fang has made a total of 4 transactions in Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Shanghai Fosun Pharmaceutical (Group) Co Ltd is the acquisition of 6,000 shares on September 13, 2022, which cost Wu Yi Fang around $207,720.

Insider Trading History of Wu Yi Fang

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wu Yi Fang Trading Performance

GuruFocus tracks the stock performance after each of Wu Yi Fang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wu Yi Fang is 5.87%. GuruFocus also compares Wu Yi Fang's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wu Yi Fang within 3 months outperforms 18 times out of 34 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Wu Yi Fang's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Wu Yi Fang

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
20 out of 34 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.11 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -5.83 LIMIT LIMIT LIMIT LIMIT LIMIT

Wu Yi Fang Ownership Network

Ownership Network List of Wu Yi Fang

No Data

Ownership Network Relation of Wu Yi Fang

Insider Network Chart

Wu Yi Fang Owned Company Details

What does Shanghai Fosun Pharmaceutical (Group) Co Ltd do?

Who are the key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd?

Wu Yi Fang is the Director of Shanghai Fosun Pharmaceutical (Group) Co Ltd. Other key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd include senior management bao qin gui , senior management Mei Jing Ping , and senior management li sheng li .

Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Shanghai Fosun Pharmaceutical (Group) Co Ltd Insider Transactions

No Available Data

Wu Yi Fang Mailing Address

Above is the net worth, insider trading, and ownership report for Wu Yi Fang. Currently GuruFocus does not have mailing address information for Wu Yi Fang.

Discussions on Wu Yi Fang

No discussions yet.